Audicin, a Finland-based developer of brain-activating audio treatments, has raised $1.9M in seed funding with participation from Oura Health co-founders Petteri Lahtela and Virpi Tuomivaara alongside a Business Finland grant. The company embeds scientifically engineered binaural beats into music and 360-degree spatial sound to promote nervous system resilience. Benefits include stress reduction, better sleep, focus, and recovery in sessions as short as 10 minutes. Funds will support SDK expansion for app integrations and U.S. market growth.
Oura Founders Bet on Passive Neurotech
This round follows a pre-seed bringing total funding to around $3M and aligns with surging interest in wearable-integrated wellness. Oura recently raised $900M at an $11B valuation amid its revenue doubling to $1B in 2025, per CNBC. Audicin differentiates through passive, biometric-adaptive audio versus active meditation tools. Its integrations with Oura, Whoop, Garmin, and Apple Health enable real-time nervous system regulation.
Chronic Stress Demands Passive Fixes
Post-pandemic burnout affects high-performers, athletes, and professionals seeking non-pharmacological relief. Current solutions like meditation apps require deliberate effort, often failing in real-life chaos. Audicin's approach runs in the background, addressing overstimulation without user interruption. Studies show its audio yields +22% HRV improvement in nurses and -5.58 bpm heart rate reduction in productivity trials, per Audicin science page.
Binaural Beats Meet Biometrics
Audicin's patent-pending true binaural beats technology, verified in labs, powers an app with 1,564 minutes of library content alongside a Bluetooth-free Sleep Headband ($299). Unlike hardware-heavy rivals, it works via standard headphones or API for developers. 360-degree spatial audio entrains brainwaves for delta sleep, theta recovery, and gamma focus states. Users report 78% retention after four weeks and 4.6 App Store stars.
As CEO Laura Avonius noted:
"Most wellness tools were built for ideal conditions, not real life."
Investor Validation from Wearables Leaders
Petteri Lahtela, Oura's co-founder and Chief Innovation Officer, provided follow-on investment signaling strategic fit with Audicin's wearable syncing. Virpi Tuomivaara, another Oura co-founder, joined as angel. Business Finland's Deep Tech Accelerator grant underscores national innovation support. This mix of mission-driven angels and government backing positions Audicin for enterprise pilots in defense and healthcare.
Petteri Lahtela added:
"Audicin doesn’t depend on user effort… like infrastructure."
Mental Wellness Market Scales Rapidly
The mental wellness market stands at $166.35B in 2024, projected to reach $256.04B by 2030 at 7.45% CAGR, according to Research and Markets. Sound therapy subsets grow amid demand for accessible tools. Competitors include Endel with over $20M raised and Brain.fm at $125K. Audicin stands out with clinical backing from 16+ studies and offline hardware.
Sound Therapy Grabs Enterprise Attention
Neurotech trends favor biometric integration and non-invasive therapies. Interaxon (Muse) has secured over $40M for EEG headbands, but requires active use. Audicin's passive model suits high-stakes settings, evidenced by an $8M sales pipeline including U.S. defense partners.
All-Female Team Blends Neuroscience and Tech
Founder CEO Laura Avonius brings 20+ years from Nokia leadership (top 5%) and Aller Media CDO roles driving 40% revenue growth. Co-founder Dr. Victoria Williamson, Chief Scientist, holds a PhD in Music Psychology with 12+ peer-reviewed papers on music's mind-body effects. Ex-Oura CSO Dr. Hannu Kinnunen advises the medical board. This expertise validates Audicin's science-first audio.
U.S. Expansion Targets Defense Sales
New capital fuels hiring for data engineering in Finland and sales roles in Texas and Austin. Partnerships like IDUN Technologies for brain data and Mamamoon for postpartum support signal product evolution. Enterprise traction includes 40% user growth, doubled iOS revenue, and 69% subscription renewal post-Audicin 2.0. Defense pilots position Audicin beyond consumer apps into regulated sectors.